What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Antibody
Nick Willcox focuses on Immunology, Myasthenia gravis, Autoantibody, Autoimmune regulator and Autoimmunity.
His work on Thymoma and Immunoglobulin G as part of general Immunology research is often related to In patient, thus linking different fields of science.
His Myasthenia gravis study combines topics in areas such as Antibody and Acetylcholine receptor.
His biological study spans a wide range of topics, including Chronic mucocutaneous candidiasis and Autoimmune polyendocrine syndrome type 1.
The various areas that Nick Willcox examines in his Autoimmune regulator study include Gene expression, IRF8 and Cell biology.
His study explores the link between Autoimmunity and topics such as Human leukocyte antigen that cross with problems in Cytokine, Interferon alfa and Alpha interferon.
His most cited work include:
- Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. (548 citations)
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines (459 citations)
- IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. (333 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Myasthenia gravis, Autoantibody, Thymoma and Acetylcholine receptor.
His is involved in several facets of Immunology study, as is seen by his studies on Autoimmunity, Antibody, Epitope, Human leukocyte antigen and Autoimmune regulator.
His work on Immunoglobulin G as part of general Antibody research is frequently linked to In patient, thereby connecting diverse disciplines of science.
His study in Myasthenia gravis is interdisciplinary in nature, drawing from both T cell, Endocrinology and Germinal center.
His studies in Autoantibody integrate themes in fields like Chronic mucocutaneous candidiasis, Cytokine and Multiple myeloma.
While the research belongs to areas of Thymoma, Nick Willcox spends his time largely on the problem of Interferon, intersecting his research to questions surrounding Autoimmune disease.
He most often published in these fields:
- Immunology (66.67%)
- Myasthenia gravis (60.98%)
- Autoantibody (26.83%)
What were the highlights of his more recent work (between 2009-2021)?
- Immunology (66.67%)
- Autoantibody (26.83%)
- Myasthenia gravis (60.98%)
In recent papers he was focusing on the following fields of study:
Immunology, Autoantibody, Myasthenia gravis, Thymoma and Autoimmune regulator are his primary areas of study.
His research on Immunology often connects related topics like Virology.
As a member of one scientific family, Nick Willcox mostly works in the field of Autoantibody, focusing on Chronic mucocutaneous candidiasis and, on occasion, Interleukin 22 and Interleukin 17.
In his study, Cell type is strongly linked to Gene, which falls under the umbrella field of Myasthenia gravis.
His Autoimmune regulator research is multidisciplinary, incorporating perspectives in Autoimmune polyendocrinopathy and Hypoparathyroidism.
He has included themes like Autoimmune polyendocrine syndrome type 1 and Mucocutaneous Candidiasis in his Autoimmune polyendocrinopathy study.
Between 2009 and 2021, his most popular works were:
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines (459 citations)
- Thymoma and paraneoplastic myasthenia gravis (114 citations)
- Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS (96 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
His primary areas of study are Immunology, Autoimmune regulator, Chronic mucocutaneous candidiasis, Thymoma and Autoimmunity.
Nick Willcox has researched Chronic mucocutaneous candidiasis in several fields, including Autoimmune polyendocrinopathy and Autoantibody.
His work in Autoimmune polyendocrinopathy covers topics such as Autoimmune polyendocrine syndrome type 1 which are related to areas like Autoimmune hepatitis, Hypoparathyroidism and Endocrinology.
His work deals with themes such as Interleukin 22 and Mucocutaneous Candidiasis, which intersect with Autoantibody.
His Thymoma research incorporates elements of Myasthenia gravis, FOXP3 and MHC class II.
His research in Myasthenia gravis intersects with topics in Lymphopoiesis, Cell, Insulin and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
